组织陈列-产品详情

home > TISSUE ARRAYS > Liver > DLV1505a

Type
- FFPE
- FROZEN TISSUE
Identity
Organ
- Liver
- Esophagus
- Ovary
- Stomach
- Lung
- Colon
- Rectum
- Kidney
- Breast
- Endometrium
- Uterus
- Bladder
- Pancreas
- Skin
- Penis
- Testis
- Soft_Tissue
- Bone/Cartilage
- Oral/Cavity
- Bone/Marrow
- Heart
- Spleen
- Head/Neck
- Vulva
- Melanoma
- Appendix
- Intestine
- Adrenal Gland
- Thymus
- Fallopian tube
- Mouse
- Fetus
- Rat
- Monkey (Rhesus) (Normal)-RsFPT
- Monkey (Cynomolgus) (Normal)-CyFPT
- Dog
- Multiple organ
- Gall bladder and bile duct
- Esophagogastric junction
Types/Disease
Cores
Cases

Cores:

150

CASES:

50

Core Diameter(mm):

1

Thickness(µm):

5

Row number:

10

Column number:

15

Tissue Array Type:

FFPE

Species:

Human

DLV1505a

$215.00

Description: Liver cancer tissue array with matched liver tissue, including pathology grade, TNM and clinical stage, 50 cases/150 cores, replacing DLV1505

Details: Hepatocellular carcinoma tissue microarray with matched liver tissue, containing 25 cases each of hepatocellular carcinoma and cholangiocellular carcinoma, with matched cancer adjacent or adjacent normal stomach tissue, duplicate cores of cancer, single core of cancer adjacent or adjacent normal tissue

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:

Unstained

H&E

Tag:

150 Cores 50 Cases Liver Matched or Unmatched duplicate cores per case Adjacent special price single core per case

Add To Cart

Outright purchase

Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

Specification sheet
Overlapping case
Download specifications

Legend:

Car-Cardia Eso-Fsophagus

AT(*)
NAT(*)
Malignant(I)
Malignant(IB)
Malignant(II)
Malignant(IIIA)
Malignant(IIIB)
Malignant(IVA)
_ma

TISSUE ARRAYS
DLV1505a

	1	2	3	4	5	6	7	8	9	10	11	12	13	14	15
A	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
B	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
C	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
D	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
E	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
F	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
G	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
H	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
I	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
J	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	_ma

DLV1505a

Age:
Sex:
Organ/Anatomic Site:
Pathology diagnosis:
Grade:
TNM:
Stage:
Tissue ID.:
Type:

Pos	No.	Age	Sex	Organ/Anatomic Site	Pathology diagnosis	Grade	TNM	Stage	Type	Tumor size
A1	1	63	M	Liver	Hepatocellular carcinoma	1	T3N0M0	IIIA	Malignant	*
A2	2	63	M	Liver	Hepatocellular carcinoma	1	T3N0M0	IIIA	Malignant	*
A3	3	63	M	Liver	Mild inflammation	*	*	*	AT	*
A4	4	65	M	Liver	Hepatocellular carcinoma with degeneration	1	T2N0M0	II	Malignant	*
A5	5	65	M	Liver	Hepatocellular carcinoma with degeneration	1	T2N0M0	II	Malignant	*
A6	6	65	M	Liver	Cirrhosis	*	*	*	NAT	*
A7	7	62	F	Liver	Hepatocellular carcinoma	1--2	T3N0M0	IIIA	Malignant	*
A8	8	62	F	Liver	Hepatocellular carcinoma	1--2	T3N0M0	IIIA	Malignant	*
A9	9	62	F	Liver	Mild inflammation	*	*	*	NAT	*
A10	10	40	M	Liver	Hepatocellular carcinoma	2	T3N1M0	IVA	Malignant	*
A11	11	40	M	Liver	Hepatocellular carcinoma	2	T3N1M0	IVA	Malignant	*
A12	12	40	M	Liver	Cirrhosis	*	*	*	AT	*
A13	13	77	M	Liver	Hepatocellular carcinoma	2	T3aN0M0	IIIA	Malignant	6.05.05.0
A14	14	77	M	Liver	Hepatocellular carcinoma	2	T3aN0M0	IIIA	Malignant	6.05.05.0
A15	15	77	M	Liver	Mild inflammation	*	*	*	NAT	*
B1	16	58	M	Liver	Hepatocellular carcinoma	2	T2N0M0	II	Malignant	776
B2	17	58	M	Liver	Hepatocellular carcinoma	2	T2N0M0	II	Malignant	776
B3	18	58	M	Liver	Moderate inflammation	*	*	*	NAT	*
B4	19	72	F	Liver	Hepatocellular carcinoma	2	T2N0M0	II	Malignant	5.55.03.5
B5	20	72	F	Liver	Hepatocellular carcinoma	2	T2N0M0	II	Malignant	5.55.03.5
B6	21	72	F	Liver	Cirrhosis	*	*	*	NAT	*
B7	22	58	F	Liver	Hepatocellular carcinoma	2	T1bN0M0	IB	Malignant	7.06.04.5
B8	23	58	F	Liver	Hepatocellular carcinoma	2	T1bN0M0	IB	Malignant	7.06.04.5
B9	24	58	F	Liver	Mild inflammation	*	*	*	NAT	*
B10	25	36	F	Liver	Hepatocellular carcinoma	2	T3N0M0	IIIA	Malignant	*
B11	26	36	F	Liver	Hepatocellular carcinoma	2	T3N0M0	IIIA	Malignant	*
B12	27	36	F	Liver	Mild inflammation	*	*	*	AT	*
B13	28	57	F	Liver	Hepatocellular carcinoma	2	T2N0M0	II	Malignant	6.55.03.5
B14	29	57	F	Liver	Hepatocellular carcinoma	2	T2N0M0	II	Malignant	6.55.03.5
B15	30	57	F	Liver	Cirrhosis	*	*	*	NAT	*
C1	31	45	M	Liver	Hepatocellular carcinoma	2	T3N0M0	IIIA	Malignant	*
C2	32	45	M	Liver	Hepatocellular carcinoma	2	T3N0M0	IIIA	Malignant	*
C3	33	45	M	Liver	Mild inflammation	*	*	*	NAT	*
C4	34	47	M	Liver	Hepatocellular carcinoma	2--3	T3N0M0	IIIA	Malignant	8.56.03.5
C5	35	47	M	Liver	Hepatocellular carcinoma	2--3	T3N0M0	IIIA	Malignant	8.56.03.5
C6	36	47	M	Liver	Mild inflammation	*	*	*	AT	*
C7	37	50	M	Liver	Hepatocellular carcinoma with necrosis	2--3	T2N0M0	II	Malignant	*
C8	38	50	M	Liver	Hepatocellular carcinoma	2--3	T2N0M0	II	Malignant	*
C9	39	50	M	Liver	Mild inflammation	*	*	*	NAT	*
C10	40	60	M	Liver	Hepatocellular carcinoma	3	T3N0M0	IIIA	Malignant	8.075
C11	41	60	M	Liver	Hepatocellular carcinoma with necrosis	3	T3N0M0	IIIA	Malignant	8.075
C12	42	60	M	Liver	Moderate inflammation	*	*	*	NAT	*
C13	43	47	M	Liver	Hepatocellular carcinoma with necrosis	3	T2N0M0	II	Malignant	3.52.52.2
C14	44	47	M	Liver	Hepatocellular carcinoma with necrosis	3	T2N0M0	II	Malignant	3.52.52.2
C15	45	47	M	Liver	Mild inflammation	*	*	*	NAT	*
D1	46	52	F	Liver	Hepatocellular carcinoma	3	T2N0M0	II	Malignant	6.04.54.5
D2	47	52	F	Liver	Hepatocellular carcinoma	3	T2N0M0	II	Malignant	6.04.54.5
D3	48	52	F	Liver	Mild-moderate inflammation	*	*	*	NAT	*
D4	49	63	M	Liver	Hepatocellular carcinoma	3	T3N0M0	IIIA	Malignant	*
D5	50	63	M	Liver	Hepatocellular carcinoma	3	T3N0M0	IIIA	Malignant	*
D6	51	63	M	Liver	Mild inflammation	*	*	*	NAT	*
D7	52	27	F	Liver	Hepatocellular carcinoma	3	T4N0M0	IIIB	Malignant	*
D8	53	27	F	Liver	Hepatocellular carcinoma	3	T4N0M0	IIIB	Malignant	*
D9	54	27	F	Liver	Mild inflammation	*	*	*	NAT	*
D10	55	51	F	Liver	Hepatocellular carcinoma	3	T2N0M0	II	Malignant	*
D11	56	51	F	Liver	Hepatocellular carcinoma	3	T2N0M0	II	Malignant	*
D12	57	51	F	Liver	Mild inflammation	*	*	*	AT	*
D13	58	51	M	Liver	Hepatocellular carcinoma	3	T3N0M0	IIIA	Malignant	*
D14	59	51	M	Liver	Hepatocellular carcinoma (sparse)	3	T3N0M0	IIIA	Malignant	*
D15	60	51	M	Liver	Cirrhosis	*	*	*	AT	*
E1	61	63	M	Liver	Hepatocellular carcinoma	2	T2N0M0	II	Malignant	4.03.52.5
E2	62	63	M	Liver	Hepatocellular carcinoma	2	T2N0M0	II	Malignant	4.03.52.5
E3	63	63	M	Liver	Cirrhosis	*	*	*	NAT	*
E4	64	69	M	Liver	Hepatocellular carcinoma	2	T3N1M0	IVA	Malignant	7
E5	65	69	M	Liver	Hepatocellular carcinoma (sparse)	2	T3N1M0	IVA	Malignant	7
E6	66	69	M	Liver	Mild inflammation	*	*	*	NAT	*
E7	67	66	M	Liver	Hepatocellular carcinoma	2	T2N1M0	IVA	Malignant	5
E8	68	66	M	Liver	Hepatocellular carcinoma (sparse)	2	T2N1M0	IVA	Malignant	5
E9	69	66	M	Liver	Nodular cirrhosis	*	*	*	NAT	*
E10	70	51	M	Liver	Hepatocellular carcinoma with necrosis	3	T3aN1M0	IVA	Malignant	6
E11	71	51	M	Liver	Hepatocellular carcinoma	3	T3aN1M0	IVA	Malignant	6
E12	72	51	M	Liver	Nodular cirrhosis	*	*	*	AT	*
E13	73	77	F	Liver	Hepatocellular carcinoma with necrosis	3	T3N0M0	IIIA	Malignant	7
E14	74	77	F	Liver	Hepatocellular carcinoma	3	T3N0M0	IIIA	Malignant	7
E15	75	77	F	Liver	Mild-moderate inflammation	*	*	*	AT	*
F1	76	67	F	Liver	Cholangiocellular carcinoma	2	T3N1M0	IIIB	Malignant	*
F2	77	67	F	Liver	Cholangiocellular carcinoma	2	T3N1M0	IIIB	Malignant	*
F3	78	67	F	Liver	Chronic hepatitis	*	*	*	AT	*
F4	79	58	F	Liver	Cholangiocellular carcinoma	2	T2N0M0	II	Malignant	*
F5	80	58	F	Liver	Cholangiocellular carcinoma with necrosis	2	T2N0M0	II	Malignant	*
F6	81	58	F	Liver	Mild inflammation	*	*	*	NAT	*
F7	82	54	M	Liver	Cholangiocellular carcinoma	2	T3N1M0	IIIB	Malignant	*
F8	83	54	M	Liver	Cholangiocellular carcinoma	2	T3N1M0	IIIB	Malignant	*
F9	84	54	M	Liver	Mild inflammation	*	*	*	NAT	*
F10	85	60	M	Liver	Cholangiocellular carcinoma	3	T2N0M0	II	Malignant	*
F11	86	60	M	Liver	Cholangiocellular carcinoma	3	T2N0M0	II	Malignant	*
F12	87	60	M	Liver	Mild inflammation	*	*	*	NAT	*
F13	88	63	M	Liver	Cholangiocellular carcinoma with necrosis	2	T3N0M0	IIIA	Malignant	*
F14	89	63	M	Liver	Cholangiocellular carcinoma with necrosis	2	T3N0M0	IIIA	Malignant	*
F15	90	63	M	Liver	Chronic hepatitis	*	*	*	NAT	*
G1	91	56	F	Liver	Cholangiocellular carcinoma	3	T2N0M0	II	Malignant	*
G2	92	56	F	Liver	Cholangiocellular carcinoma	3	T2N0M0	II	Malignant	*
G3	93	56	F	Liver	Mild inflammation	*	*	*	NAT	*
G4	94	52	M	Liver	Cholangiocellular carcinoma with degenerate	2	T1N0M0	I	Malignant	7*5
G5	95	52	M	Liver	Cholangiocellular carcinoma with degenerate	2	T1N0M0	I	Malignant	7*5
G6	96	52	M	Liver	Mild inflammation	*	*	*	NAT	*
G7	97	42	M	Liver	Cholangiocellular carcinoma	2	T1N1M0	IIIB	Malignant	6
G8	98	42	M	Liver	Cholangiocellular carcinoma	2	T1N1M0	IIIB	Malignant	6
G9	99	42	M	Liver	Mild inflammation	*	*	*	NAT	*
G10	100	57	F	Liver	Cholangiocellular carcinoma	2--3	T2N1M0	IIIB	Malignant	*
G11	101	57	F	Liver	Cholangiocellular carcinoma	2--3	T2N1M0	IIIB	Malignant	*
G12	102	57	F	Liver	Mild-moderate inflammation	*	*	*	NAT	*
G13	103	68	F	Liver	Cholangiocellular carcinoma with necrosis	2--3	T2N0M0	II	Malignant	4.03.53
G14	104	68	F	Liver	Cholangiocellular carcinoma with necrosis	2--3	T2N0M0	II	Malignant	4.03.53
G15	105	68	F	Liver	Mild inflammation	*	*	*	NAT	*
H1	106	41	M	Liver	Cholangiocellular carcinoma	2--3	T3N0M0	IIIA	Malignant	433
H2	107	41	M	Liver	Cholangiocellular carcinoma with necrosis	2--3	T3N0M0	IIIA	Malignant	433
H3	108	41	M	Liver	Mild inflammation	*	*	*	NAT	*
H4	109	60	F	Liver	Cholangiocellular carcinoma	2--3	T2aN0M0	II	Malignant	32.52.5
H5	110	60	F	Liver	Cholangiocellular carcinoma	2--3	T2aN0M0	II	Malignant	32.52.5
H6	111	60	F	Liver	Chronic active hepatitis	*	*	*	AT	*
H7	112	55	M	Liver	Cholangiocellular carcinoma	2--3	T3N0M0	IIIA	Malignant	*
H8	113	55	M	Liver	Cholangiocellular carcinoma with necrosis	2--3	T3N0M0	IIIA	Malignant	*
H9	114	55	M	Liver	Mild inflammation	*	*	*	AT	*
H10	115	62	M	Liver	Cholangiocellular carcinoma with necrosis	2--3	T2aN0M0	II	Malignant	6
H11	116	62	M	Liver	Cholangiocellular carcinoma with necrosis	2--3	T2aN0M0	II	Malignant	6
H12	117	62	M	Liver	Mild inflammation	*	*	*	NAT	*
H13	118	46	M	Liver	Cholangiocellular carcinoma	3	T2aN0M0	II	Malignant	*
H14	119	46	M	Liver	Cholangiocellular carcinoma	3	T2aN0M0	II	Malignant	*
H15	120	46	M	Liver	Mild inflammation	*	*	*	NAT	*
I1	121	53	M	Liver	Cholangiocellular carcinoma	3	T3N0M0	IIIA	Malignant	*
I2	122	53	M	Liver	Cholangiocellular carcinoma with necrosis	3	T3N0M0	IIIA	Malignant	*
I3	123	53	M	Liver	Nodular cirrhosis	*	*	*	AT	*
I4	124	51	M	Liver	Cholangiocellular carcinoma with necrosis	3	T4N1M0	IIIB	Malignant	6
I5	125	51	M	Liver	Cholangiocellular carcinoma with necrosis	3	T4N1M0	IIIB	Malignant	6
I6	126	51	M	Liver	Moderate inflammation	*	*	*	NAT	*
I7	127	60	F	Liver	Cholangiocellular carcinoma	2	T3N0M0	IIIA	Malignant	7
I8	128	60	F	Liver	Cholangiocellular carcinoma	2	T3N0M0	IIIA	Malignant	7
I9	129	60	F	Liver	Mild-moderate inflammation	*	*	*	NAT	*
I10	130	46	M	Liver	Cholangiocellular carcinoma with necrosis	3	T1N1M0	IIIB	Malignant	4
I11	131	46	M	Liver	Cholangiocellular carcinoma (sparse)	3	T1N1M0	IIIB	Malignant	4
I12	132	46	M	Liver	Mild inflammation	*	*	*	NAT	*
I13	133	56	M	Liver	Cholangiocellular carcinoma	2	T4N1M0	IIIB	Malignant	6
I14	134	56	M	Liver	Cholangiocellular carcinoma	2	T4N1M0	IIIB	Malignant	6
I15	135	56	M	Liver	Mild-moderate inflammation	*	*	*	NAT	*
J1	136	64	M	Liver	Cholangiocellular carcinoma with necrosis	2--3	T3N0M0	IIIA	Malignant	7
J2	137	64	M	Liver	Cholangiocellular carcinoma	2--3	T3N0M0	IIIA	Malignant	7
J3	138	64	M	Liver	Mild inflammation	*	*	*	NAT	*
J4	139	69	M	Liver	Cholangiocellular carcinoma	2	T3aN0M0	IIIA	Malignant	6
J5	140	69	M	Liver	Cholangiocellular carcinoma	2	T3aN0M0	IIIA	Malignant	6
J6	141	69	M	Liver	Mild inflammation	*	*	*	NAT	*
J7	142	57	M	Liver	Cholangiocellular carcinoma	2	T3N0M0	IIIA	Malignant	9
J8	143	57	M	Liver	Cholangiocellular carcinoma	2	T3N0M0	IIIA	Malignant	9
J9	144	57	M	Liver	Cirrhosis	*	*	*	NAT	*
J10	145	42	M	Liver	Cholangiocellular carcinoma with necrosis	2	T3N0M0	IIIA	Malignant	3
J11	146	42	M	Liver	Cholangiocellular carcinoma	2	T3N0M0	IIIA	Malignant	3
J12	147	42	M	Liver	Moderate inflammation	*	*	*	NAT	*
J13	148	59	M	Liver	Cholangiocellular carcinoma	2	T3N1M0	IIIB	Malignant	*
J14	149	59	M	Liver	Cholangiocellular carcinoma with necrosis	2	T3N1M0	IIIB	Malignant	*
J15	150	59	M	Liver	Nodular cirrhosis	*	*	*	NAT	*
_marker_

Find overlapping cases with this tissue array:

DLV1505a

File Format: .xlsx

Release Date: 2025-01-17 15:53:43
Download

	1	2	3	4	5	6	7	8	9	10	11	12	13	14	15
A	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
B	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
C	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
D	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
E	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
F	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
G	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
H	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
I	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
J	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	_ma

	1	2	3	4	5	6	7	8	9	10	11	12	13	14	15
A	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
B	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
C	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
D	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
E	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
F	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
G	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
H	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
I	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
J	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	_ma

	1	2	3	4	5	6	7	8	9	10	11	12	13	14	15
A	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
B	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
C	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
D	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
E	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
F	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
G	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
H	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
I	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
J	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	_ma